Research Funding
Hemophilia of Georgia (HoG) is committed to advancing scientific discovery and improving quality of life for individuals with a bleeding disorder. Through our Research Grants & Community Support Grants, we fund innovative projects that:
-
Expand the understanding of bleeding disorders
-
Support the development of new treatments and potential cures
-
Strengthen the bleeding disorder community through education, advocacy, and health care initiatives
These grants are a vital part of HoG’s mission to lead progress in both clinical research and community health.
Funding Opportunities
HoG offers a variety of grant programs that typically open for applications in the early part of each calendar year. These opportunities are designed to support early-career researchers, collaborative clinical studies, and community-based health initiatives. For grant policies, eligibility criteria, and application materials, please contact: Grants Management Coordinator – dpbernard@hog.org
Research Grants:
• Hemophilia of Georgia Bleeding Disorders Clinical Scientist Development Grant
• Hemophilia of Georgia Research and Development Grant
Community Support Grants:
• Hemophilia of Georgia Community Support Grant
• Hemophilia of Georgia Community Support Grant- International
Funding Opportunities outside of HoG that have been funded by HoG:
Judith Graham Pool Postdoctoral Research Fellowships
Hemophilia of Georgia has been a long-time supporter of the JGP Research Fellowship program by the National Bleeding Disorders Foundation. HoG has fully funded and endowed the program to ensure continued basic research into bleeding disorders.
Current Funded Research: A Proven Commitment to Research at Every Level
Hemophilia of Georgia (HoG) has built a distinguished legacy of supporting impactful research across local, regional, and national platforms. From funding cutting-edge studies at Georgia-based institutions to contributing to nationwide initiatives and data-driven collaborations, HoG plays a pivotal role in advancing the science and care of bleeding disorders.
This multi-tiered approach ensures that our investments benefit the communities we serve directly while also contributing to broader innovations that shape the future of treatment, prevention, and patient outcomes across the country.
Hemophilia of Georgia provides funding for research by the Infectious Disease/Hemophilia Program at Emory Midtown and the Hemophilia Treatment Centers at Augusta University, Emory University/Children’s Healthcare of Atlanta (CHOA), and Memorial Health University Medical Center at Savannah. Their research includes not only inherited bleeding disorders but also HIV and hepatitis C.
Gene Therapy Research: Advancing Research Toward A Cure
Since 2012, Hemophilia of Georgia has funded gene therapy research at two institutions: The Aflac Cancer and Blood Disorders Center at Emory University, Atlanta and St. Jude Children’s Research Hospital in Memphis, Tennessee. Our contributions of over $8 million are to develop a cure for hemophilia (factor VIII, factor IX, and factor VII deficiencies).
Funding for the American Thrombosis and Hemostasis Network
Hemophilia of Georgia helped establish ATHN, a nonprofit dedicated to improving care for individuals with bleeding and thrombotic disorders through a secure national database. Funded ATHN Projects:
- ATHN 5: Comparing Hepatitis C treatment regimens for patients with bleeding disorders
- 2016 and 2018 ATHN DREAM Award: Designed to enhance the care of patients with bleeding and clotting disorders, the award provides grants of up to $100,000 over 24 months for mentored research by young clinical scientist
- ATHN 8: U.S. Cohort Study of Previously Untreated Patients (PUPs) with congenital hemophilia
- WAPPS-Hemo Integration & PRO Application Projects
Stay up-to-date on the research programs we fund by subscribing to our newsletter.